West Paces Advisors’s Sanofi SNY Stock Holding History

West Paces Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-42	Closed	-$2.21K	–	632
2021 Q2	$2.21K	Buy	+42	New	+$2.19K	﹤0.01%	529

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

West Paces Advisors's SNY Position: Q3 2021 in Review

West Paces Advisors sold out of Sanofi (SNY) in Q3 2021, closing a stake of 42 shares — an estimated $2.21K sold.

West Paces Advisors first reported a position in SNY in Q2 2021 and held it in 1 quarter. The position peaked at $2.21K in Q2 2021. 576 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

West Paces Advisors reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
West Paces Advisors sold 42 Sanofi shares in Q3 2021, an estimated $2.21K.
West Paces Advisors first reported a position in Sanofi in Q2 2021 and held it in 1 quarter.
West Paces Advisors's Sanofi position peaked at $2.21K in Q2 2021.
576 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on West Paces Advisors's 13F filing for Q3 2021, filed 20 Dec 2023.